Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 10-2005 | 10-2004 | 10-2003 | 10-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 108,400 | 66,200 | 718,700 | 278,900 |
| Marketable Securities | N/A | 335,300 | 434,600 | 26,700 | 500 |
| Receivables | N/A | 207,600 | 191,000 | 112,900 | 267,500 |
| Inventories | N/A | 140,400 | 97,600 | 57,100 | 94,900 |
| Other current assets | 0 | 29,600 | 22,000 | 74,100 | 0 |
| TOTAL | $N/A | $854,800 | $836,100 | $1,032,200 | $686,300 |
| Non-Current Assets | |||||
| PPE Net | N/A | 220,400 | 232,500 | 175,300 | 206,800 |
| Investments And Advances | 0 | 12,100 | 26,800 | 19,500 | 0 |
| Intangibles | 0 | 405,500 | 273,100 | 12,800 | 0 |
| Other Non-Current Assets | 0 | 44,400 | 59,600 | 57,100 | 251,100 |
| TOTAL | $N/A | $682,400 | $592,000 | $264,700 | $457,900 |
| Total Assets | $N/A | $1,537,200 | $1,428,100 | $1,296,900 | $1,144,200 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 69,600 | 72,500 | 43,900 | 73,000 |
| Accrued Expenses | N/A | 108,500 | 104,000 | 72,800 | 198,300 |
| TOTAL | $N/A | $288,800 | $302,000 | $266,800 | $397,800 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 400,000 | 400,000 | 400,000 | 10,800 |
| Other Non-Current Liabilities | 0 | 74,500 | 66,800 | 2,400 | 3,400 |
| TOTAL | $N/A | $474,500 | $466,800 | $402,400 | $14,200 |
| Total Liabilities | $N/A | $763,300 | $768,800 | $669,200 | $412,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 116,801 | 115,814 | 115,197 | 114,566 |
| Common Shares | N/A | 23,300 | 162,000 | 161,300 | 159,900 |
| Retained earnings | N/A | -622,900 | -733,600 | -750,000 | -673,300 |
| Other shareholders' equity | 0 | -24,400 | -19,900 | -30,500 | -27,000 |
| TOTAL | $N/A | $773,900 | $659,300 | $627,700 | $732,200 |
| Total Liabilities And Equity | $0 | $1,537,200 | $1,428,100 | $1,296,900 | $1,144,200 |